AR Asset Management Inc. purchased a new position in Marker Therapeutics, Inc. (NASDAQ:MRKR – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 40,700 shares of the company’s stock, valued at approximately $29,000. Separately, Renaissance Technologies LLC increased its stake in Marker Therapeutics […]